The KickStart Award Program helps early-stage companies meet commercial milestones, either on the technical side (prototype development, animal studies) or on the business side (regulatory pathway, freedom to operate).

Requests for proposals (RFAs) are solicited on a quarterly basis from faculty founders. The awards are in the $5,000 to $50,000 range, depending the on the company’s needs.

The program also provides funding and access to internal and external business experts to assist faculty with the commercial translation of concepts for novel therapeutic small molecules, biologics, diagnostics, devices or digital health. Applicants are encouraged to reach out to KickStart prior to submission to ensure the funding opportunity objectives and solicitation are aligned. Please email Mireya McKee for more information.

Application Submission

  • Applications are accepted only through a web-based application system (see RFA).
  • For eligibility and important information regarding the application process, please see the RFA.
  • Deadline: January 31, 2020.
G1 Therapeutics
Enci Therapeutics
Capture Pharma
Hibernaid
Synereca
X-in-8
Cell Microsystems
Ironwood Material Science
Novolipid
Lotus Bio FX
Neurogate Therapeutics
Qualiber
BioDeptronix LLC
Novametics
KindHeart
KXT Bio
Plex Diagnostics
Symberix
Augment Medical
Meryx Pharmaceuticals
Glycan Therapeutics
Spirovation
Healthspan Dx
New Paradigm Therapeutics
Spyryx LLC
Serratta LLC
Eppin Pharma
Reveris LLC
SonoVol LLC
Symberix LLC
Duologics LLC
Joe Startup Technologies
Enzerna Biosciences
Neuronano Pharma
Premirr Plastics LLC
Renovion Inc
Initos Pharmaceuticals
Iris Biomed
Pulvinar
Anelleo
SandBar Oyster Co.
SeqQuest
Altis Biosystems
Empower RT
Irex Pharma
Eldec Pharmaceuticals
Sono Vascular
Bedrock Therapeutics
PrimeNeuro LLC
Sove, Inc.
BMPolytech
Perotech Corporation
Assure Technologies
GoodBowls
STATApps